http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106754929-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-107 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate | 2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106754929-B |
| titleOfInvention | Model and application of the restructuring of FOXL2 promoter genes with structure |
| abstract | The present invention relates to model and application of the restructuring of people's plug transcription factor FOXL2 promoter luciferase reporting genes with structure.Expanded using technique for gene engineering from human genome and obtained 1931 bp FOXL2 promoter sequences, and be cloned on pGL3 luc carriers, structure Pro FOXL2::Luc expression vectors.DLR detections confirm that FOXL2 expression is regulated and controled by promoter region, and structure FOXL2 promoter models are to screen which traditional Chinese medicine ingredients can suppress the committed step of oophoroma.By this model, screening medicine is used for the transcription for suppressing FOXL2 promoters, and theoretical foundation and medication filtering mode can be provided for clinical treatment. |
| priorityDate | 2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.